Mr. Craig MacPhail reports

NUMINUS PROVIDES BI-WEEKLY UPDATE ON ANNUAL FILINGS

Numinus Wellness Inc. has provided an update with respect to its previously announced management cease trade order (MCTO) in connection with the company's filing of its audited annual financial statements, the management's discussion and analysis (MD&A), and the annual information form (AIF), for the financial year ended Aug. 31, 2024, and the applicable chief executive officer and chief financial officer certifications.

Further to the company's news release dated Dec. 3, 2024, the company's principal regulator, the British Columbia Securities Commission, granted the MCTO on Dec. 2, 2024, under National Policy 12-203, Management Cease Trader Orders. Pursuant to the MCTO, the CEO and the chief financial officer of the company may not trade in securities of the company until such time as the company files the annual filings and the commission revokes the MCTO. During this period, the company will cease any share buyback activities under its normal course issuer bid, and has undertaken not to, directly or indirectly, issue or acquire securities from an insider or employee of the company.

The MCTO does not affect the ability of shareholders to trade their securities.

The company's board of directors and management are continuing to work with its accounting team to prepare the annual filings as soon as practicable. The delay in filing the annual filings is a result of unexpected delays experienced by the company. It is the company's reasonable expectation that the annual filings will be finalized by Jan. 28, 2025.

The company will issue a news release announcing completion of filing of the annual filings at such time as they are completed and filed. Until the company files the annual filings, it will comply with the alternative information guidelines set out in under NP 12-203, including issuing biweekly default status reports by way of news releases, which will be filed on SEDAR+.

In addition, the company confirms that since the date of ahe Announcement: (i) there has been no failure by the company in fulfilling its stated intentions with respect to satisfying the provisions of the alternative information guidelines set out in NP 12-203; (ii) there has not been any other specified default by the company under NP 12-203; (iii) the company is not subject to any insolvency proceedings; and (iv) there is no other material information concerning the affairs of the company that has not been generally disclosed.

About Numinus Wellness Inc.

Numinus Wellness helps people to heal and be well through the development and delivery of innovative mental health care and access to safe, evidence-based psychedelic-assisted therapies. The Numinus model, including psychedelic research and clinic care, is at the forefront of a transformation aimed at healing rather than managing symptoms of depression, anxiety, trauma, pain and substance use. Numinus is leading the integration of psychedelic-assisted therapies into mainstream clinical practice and building the foundation for a healthier society.

We seek Safe Harbor.